Europe is home to more than 38,000 medical technology companies, ranging from multinational manufacturers to specialised SMEs developing medical devices, in vitro diagnostics, digital health products and enabling technologies.
This guide provides an overview of the European MedTech market, representative companies, the principal industry hubs and the regulatory considerations that organisations should assess when entering or expanding across Europe.
The companies mentioned are examples, not a ranking or an exhaustive directory. Corporate structures, product portfolios and market presence can change, so each organisation should be verified through its official website and the relevant regulatory sources.
How Many MedTech Companies Are There in Europe?
According to MedTech Europe, there are more than 38,000 medical technology companies operating in Europe. Approximately 90% are small and medium-sized enterprises, and the industry directly employs more than 930,000 people.
| Indicator | Current European market data |
|---|---|
| Medical technology companies | More than 38,000 |
| Direct employment | More than 930,000 people |
| Companies classified as SMEs | Approximately 90% |
| Estimated market value in 2024 | Approximately €170 billion |
| Share of the global market | 26.4% |
| Global market position | Second after the United States |
These figures cover the broader European market, which includes EU Member States and important non-EU markets such as the United Kingdom and Switzerland. These countries participate in the European MedTech ecosystem but follow different regulatory requirements.
Source: MedTech Europe Data Hub.
What Types of MedTech Companies Operate in Europe?
The European MedTech sector includes several distinct groups:
- Medical device manufacturers developing surgical instruments, implants, monitoring systems, hospital equipment and diagnostic imaging technologies.
- IVD manufacturers producing laboratory assays, molecular diagnostics, companion diagnostics and point-of-care tests.
- Software and digital health companies developing medical device software, clinical decision support systems, remote monitoring platforms and AI-enabled technologies.
- Component and technology suppliers providing sensors, electronics, materials, microfluidics, packaging and manufacturing services.
- Clinical, regulatory and quality partners supporting evidence generation, conformity assessment preparation and post-market activities.
- Distributors and local representatives supporting commercialisation and regulatory presence in individual markets.
A company list should therefore be filtered by technology, intended purpose and role in the value chain. A broad search for “MedTech companies” may otherwise combine manufacturers, distributors, software developers and service providers with very different capabilities.
Representative MedTech Companies by Country
The following examples illustrate the diversity of the European industry. They are not presented as a commercial ranking.
| Country or region | Representative companies | Areas represented |
|---|---|---|
| Germany | Siemens Healthineers, B. Braun, Dräger, Karl Storz | Imaging, hospital equipment, surgical instruments and critical care |
| France | bioMérieux, Guerbet, Sebia, Thuasne | IVDs, diagnostic imaging and medical devices |
| Netherlands | Philips, QIAGEN, Demcon, MIMETAS | Imaging, diagnostics, engineering and organ-on-chip technology |
| Spain | Werfen, Grifols, BioSystems, iVascular | IVDs, diagnostics and cardiovascular devices |
| Italy | DiaSorin, Esaote, GVS, Stevanato Group | IVDs, imaging, filtration and drug delivery technologies |
| United Kingdom | Smith+Nephew, Convatec, Oxford Instruments, CMR Surgical | Orthopaedics, wound care, imaging and surgical robotics |
| Switzerland | Roche Diagnostics, Straumann, Sonova, Ypsomed | Diagnostics, dental devices, hearing care and drug delivery |
| Nordic countries | Getinge, Elekta, Mölnlycke, Coloplast, Ambu | Hospital equipment, radiotherapy, wound care and endoscopy |
A company’s presence in Europe does not necessarily mean that it is headquartered there. Many US and Asian manufacturers also operate European subsidiaries, distribution networks and regulatory entities.
Europe’s Main MedTech Hubs
Germany
Germany has the highest number of MedTech companies in Europe and is also the continent’s largest medical technology market. Important clusters include Tuttlingen for surgical instruments, Munich for imaging and digital health, and several diagnostics and healthcare technology clusters across North Rhine-Westphalia and Hamburg.
France
France combines a large domestic healthcare market with established diagnostics, imaging and medical device manufacturers. Paris, Lyon and Grenoble are important centres for biotechnology, digital health, IVDs and medical technology research.
The Netherlands
The Netherlands has a strong ecosystem around medical imaging, high-precision engineering, diagnostics, digital health and university spin-offs. Eindhoven is particularly relevant because of its concentration of engineering expertise and specialist suppliers.
Spain
Spain has active MedTech clusters in Barcelona, Madrid and the Basque Country. Its ecosystem includes IVD manufacturers, cardiovascular device companies, digital health businesses and research organisations. Spain can also provide access to experienced clinical sites and Spanish-speaking operational teams.
Italy
Italy has one of Europe’s largest numbers of medical technology companies. Its strengths include diagnostics, medical imaging, disposables, components and specialist manufacturing, with major clusters in Lombardy, Emilia-Romagna, Veneto and Piedmont.
United Kingdom
The United Kingdom remains a significant European MedTech market and research centre, particularly around London, Cambridge, Oxford and the Midlands. However, Great Britain operates a regulatory framework that is separate from the EU system.
Switzerland
Switzerland is a major centre for diagnostics, dental technologies, hearing devices, drug delivery systems and precision manufacturing. It is not an EU Member State, and companies must assess Swiss market access requirements separately from EU MDR or IVDR compliance.
Where Can You Find Lists of European MedTech Companies?
No single public directory includes every MedTech company operating in Europe. A reliable search normally combines several sources.
MedTech Europe Members
The MedTech Europe members directory lists corporate members, associate members and national industry associations.
It is a useful starting point, but it is not a directory of all 38,000 European MedTech companies. Many SMEs appear only through national or regional associations.
National Industry Associations
National associations can provide more detailed local membership information. Examples include BVMed in Germany, SNITEM in France, FENIN in Spain, ABHI in the United Kingdom and Confindustria Dispositivi Medici in Italy.
These directories are particularly useful when searching for local manufacturers, distributors, technology suppliers or commercial partners.
Regulatory Databases
Regulatory databases should be used to verify legal manufacturers, authorised representatives, registered actors and device information.
Since 28 May 2026, four EUDAMED modules have become mandatory: Actor Registration, UDI and Device Registration, Notified Bodies and Certificates, and Market Surveillance. The Clinical Investigations and Performance Studies module and the Vigilance and Post-Market Surveillance module follow separate implementation timelines.
EUDAMED is a regulatory database, not a commercial ranking or general company directory.
How to Build a Useful MedTech Company Shortlist
1. Define the type of company required
Specify whether the search concerns a manufacturer, distributor, development partner, clinical research organisation, laboratory, authorised representative or technology supplier.
2. Filter by technology and intended purpose
A company experienced in orthopaedic implants may not be suitable for an IVD, medical device software or companion diagnostic programme. The shortlist should reflect the product, risk classification and evidence requirements.
3. Verify relevant market experience
Confirm that the company has experience in the intended EU countries and understands the applicable regulatory, clinical, language and operational requirements.
4. Request documented evidence
Evaluate relevant projects, team qualifications, quality systems, procedures, subcontracting arrangements and experience with the applicable device category. Verbal assurances should not replace documented evidence.
5. Assess regulatory and clinical fit
For regulated development programmes, determine whether the organisation can support the required clinical evaluation, performance evaluation, investigation, technical documentation or post-market activities.
Regulatory Considerations for Companies Entering Europe
For access to the EU market, manufacturers must determine whether their product falls under Regulation (EU) 2017/745 on medical devices or Regulation (EU) 2017/746 on in vitro diagnostic medical devices.
The principal considerations include:
- Product qualification and classification.
- Selection of the applicable conformity assessment route.
- Technical documentation and demonstration of conformity with the General Safety and Performance Requirements.
- Clinical evaluation for medical devices or performance evaluation for IVDs.
- An appropriate quality management system. ISO 13485 is widely used to demonstrate structured quality management, but the precise obligations depend on the product and conformity assessment route.
- Notified Body involvement when required by the device or IVD classification.
- Appointment of an EU Authorised Representative when the manufacturer is established outside the EU.
- UDI, actor, device and certificate registration obligations in EUDAMED.
- Post-market surveillance, vigilance and periodic reporting.
A CE mark supports access across the EU, but it does not eliminate every national requirement. Language, reimbursement, procurement, distribution and certain registration obligations may still vary by country.
Companion diagnostics are generally classified as class C under the IVDR. Their conformity assessment includes consultation with a medicines authority or the European Medicines Agency, depending on the associated medicinal product.
The United Kingdom and Switzerland Require Separate Planning
Great Britain continues to accept qualifying CE-marked medical devices under transitional arrangements. Depending on the applicable legislation and product, current acceptance periods extend to 30 June 2028 or 30 June 2030.
Manufacturers must also consider MHRA registration and the appointment of a UK Responsible Person when they are established outside the United Kingdom.
Switzerland is outside the EU regulatory system. Manufacturers should separately assess Swiss registration, representative and market access obligations rather than assuming that EU compliance automatically covers Switzerland.
Planning a European Clinical or Regulatory Programme?
MDx CRO supports medical device and IVD companies with European regulatory strategy, clinical evidence planning, clinical investigations, performance studies, technical documentation and representative services.
Relevant services include:
- MedTech Clinical Solutions
- Regulatory Affairs and Technical Documentation
- EU Authorised Representative and UK Responsible Person Services
Contact MDx CRO to discuss the product, intended markets and current development stage.
Frequently Asked Questions
MedTech Europe reports that more than 38,000 medical technology companies operate across Europe. Approximately 90% are SMEs.
Germany has the highest number of medical technology companies in Europe. It is followed by Italy, the United Kingdom, France and Switzerland, according to MedTech Europe.
No. It includes corporate members and national associations, but it does not represent every MedTech company operating in Europe.
Germany is the largest European medical technology market. France, the United Kingdom, Italy and Spain are also among the five largest markets.
A manufacturer established outside the EU must appoint an EU Authorised Representative before placing a device on the EU market, subject to the applicable MDR or IVDR requirements.
Not automatically. Great Britain currently accepts qualifying CE-marked devices under transitional arrangements, but it has separate registration and representative requirements. Switzerland also has its own market access obligations.
